Go Pro
→ Someone just dumped the biggest gold fund. (From Behind the Markets) (Ad)tc pixel Free NAKAW Stock Alerts

Kindly MD (NAKAW) Financials

$0.30 0.00 (0.00%)
As of 08/21/2026 10:56 AM Eastern
Compare
Annual Income Statements for Kindly MD

Annual Income Statements for Kindly MD

This table shows Kindly MD's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2023 2024 2025
Period end date 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders		 -1.62 -3.62 -52
Consolidated Net Income / (Loss)		 -1.62 -3.62 -52
Net Income / (Loss) Continuing Operations		 -1.62 -3.62 -52
Total Pre-Tax Income 		-1.62 -3.62 -52
Total Operating Income		 -1.62 -3.35 -197
Total Gross Profit		 3.77 2.72 1.82
Total Revenue		 3.77 2.72 1.82
Operating Revenue		 3.77 2.72 1.82
Total Cost of Revenue		 0.00 0.00 0.00
Total Operating Expenses		 5.39 6.07 199
Selling, General & Admin Expense		 1.36 1.91 12
Depreciation Expense		 0.11 0.14 0.08
Other Operating Expenses / (Income)		 3.92 4.02 187
Total Other Income / (Expense), net		 0.00 -0.27 145
Interest Expense		 0.06 0.43 22
Other Income / (Expense), net		 0.06 0.16 167
Income Tax Expense		 0.00 0.00 0.00
Basic Earnings per Share		 ($0.36) ($0.67) ($0.26)
Weighted Average Basic Shares Outstanding		 4.50M 5.39M 200.20M
Diluted Earnings per Share		 ($0.36) ($0.67) ($0.26)
Weighted Average Diluted Shares Outstanding		 4.50M 5.39M 200.20M
Weighted Average Basic & Diluted Shares Outstanding		 - 6.03M 690.02M

Quarterly Income Statements for Kindly MD

This table shows Kindly MD's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
Net Income / (Loss) Attributable to Common Shareholders		 -0.32 -0.28 -1.32 -1.01 -1.00 -1.04 -2.41 -86 37 -239 -133
Consolidated Net Income / (Loss)		 -0.32 -0.28 -1.32 -1.01 -1.00 -1.04 -2.41 -86 37 -239 -133
Net Income / (Loss) Continuing Operations		 -0.32 -0.28 -1.32 -1.01 -1.00 -1.04 0.00 -86 37 -239 -131
Total Pre-Tax Income 		-0.32 -0.28 -1.32 -1.01 -1.00 -1.04 0.00 -86 37 -239 -153
Total Operating Income		 -0.30 -0.24 -1.04 -1.05 -1.02 -1.04 0.00 -10 -183 -126 -149
Total Gross Profit		 0.76 0.83 0.64 0.65 0.60 0.58 0.00 0.39 0.44 2.68 36
Total Revenue		 0.76 0.83 0.64 0.65 0.60 0.58 0.00 0.39 0.44 2.68 36
Operating Revenue		 0.76 0.83 0.64 0.65 0.60 0.58 0.00 0.39 0.44 2.68 36
Total Cost of Revenue		 - 0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00 0.00
Total Operating Expenses		 1.06 1.07 1.68 1.70 1.63 1.62 0.00 11 184 129 185
Selling, General & Admin Expense		 0.27 0.29 0.44 0.53 0.65 0.59 0.00 4.98 5.07 9.78 4.70
Depreciation Expense		 0.03 0.02 0.03 0.03 0.06 0.02 0.00 0.01 0.04 1.12 2.43
Other Operating Expenses / (Income)		 0.76 0.72 0.86 1.15 1.30 1.01 0.00 5.80 179 118 73
Impairment Charge		 - - - - - - 0.00 - - - 105
Total Other Income / (Expense), net		 -0.02 -0.05 -0.28 0.04 0.02 0.00 0.00 -76 221 -113 -3.54
Interest Expense		 0.04 0.06 0.36 0.01 0.01 0.01 0.00 14 7.32 4.22 4.02
Other Income / (Expense), net		 0.01 0.01 0.07 0.05 0.03 0.01 0.00 -61 228 -108 0.47
Income Tax Expense		 - 0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00 -21
Net Income / (Loss) Discontinued Operations		 - - - - - - -2.41 - - - -1.80
Basic Earnings per Share		 ($0.08) ($0.06) ($0.26) ($0.17) ($0.18) ($0.17) ($14.20) ($0.42) $0.68 ($0.38) ($6.65)
Weighted Average Basic Shares Outstanding		 4.50M 4.62M 5.01M 5.94M 5.39M 6.03M 170.00 203.09M 200.20M 636.47M 20M
Diluted Earnings per Share		 ($0.08) ($0.06) ($0.26) ($0.17) ($0.18) ($0.17) ($14.20) ($0.42) $0.68 ($0.38) ($6.65)
Weighted Average Diluted Shares Outstanding		 4.50M 4.62M 5.01M 5.94M 5.39M 6.03M 170.00 203.09M 200.20M 636.47M 20M
Weighted Average Basic & Diluted Shares Outstanding		 0.00 5.94M 5.95M 5.98M 6.03M 6.02M 7.61M 439.85M 690.02M 696.09M 17.89M

Annual Cash Flow Statements for Kindly MD

This table details how cash moves in and out of Kindly MD's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2023 2024 2025
Period end date 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents		 0.34 1.75 20
Net Cash From Operating Activities		 -0.45 -3.07 -24
Net Cash From Continuing Operating Activities		 -0.45 -3.07 -24
Net Income / (Loss) Continuing Operations		 -1.62 -3.62 -52
Consolidated Net Income / (Loss)		 -1.62 -3.62 -52
Depreciation Expense		 0.11 0.14 0.08
Amortization Expense		 0.12 0.46 2.98
Non-Cash Adjustments To Reconcile Net Income		 0.75 0.24 30
Changes in Operating Assets and Liabilities, net		 0.19 -0.29 -4.06
Net Cash From Investing Activities		 -0.01 -0.40 -680
Net Cash From Continuing Investing Activities		 -0.01 -0.40 -680
Purchase of Property, Plant & Equipment		 -0.01 -0.40 -0.23
Acquisitions		 - - 0.19
Purchase of Investments		 - 0.00 -30
Sale and/or Maturity of Investments		 - 0.00 5.05
Other Investing Activities, net		 - 0.00 -655
Net Cash From Financing Activities		 0.80 5.22 724
Net Cash From Continuing Financing Activities		 0.80 5.22 724
Repayment of Debt		 -0.06 -0.66 -204
Repurchase of Common Equity		 0.00 -0.02 -0.32
Issuance of Debt		 0.86 0.05 192
Issuance of Common Equity		 0.00 5.86 524
Other Financing Activities, net		 0.00 -0.00 212
Cash Interest Paid		 0.03 0.02 0.00
Cash Income Taxes Paid		 0.00 0.00 0.00

Quarterly Cash Flow Statements for Kindly MD

This table details how cash moves in and out of Kindly MD's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
Net Change in Cash & Equivalents		 0.37 -0.24 4.45 -1.10 -1.37 -1.13 4.88 18 -1.60 13 -15
Net Cash From Operating Activities		 -0.21 -0.21 -0.91 -1.05 -0.90 -0.87 -1.91 -13 -7.57 -23 -3.25
Net Cash From Continuing Operating Activities		 -0.21 -0.21 -0.91 -1.05 -0.90 -0.87 -1.91 -13 -7.57 -23 -1.11
Net Income / (Loss) Continuing Operations		 -0.32 -0.28 -1.32 -1.01 -1.00 -1.04 -2.41 -86 37 -239 -133
Consolidated Net Income / (Loss)		 -0.32 -0.28 -1.32 -1.01 -1.00 -1.04 -2.41 -86 37 -239 -133
Depreciation Expense		 0.03 0.02 0.03 0.03 0.06 0.02 0.01 0.01 0.04 1.12 2.41
Non-Cash Adjustments To Reconcile Net Income		 0.08 -0.02 0.01 0.12 0.13 0.08 0.72 76 -47 221 141
Changes in Operating Assets and Liabilities, net		 -0.06 -0.01 0.03 -0.21 -0.11 0.08 -0.27 -4.19 0.30 -6.24 -11
Net Cash From Investing Activities		 - -0.01 - -0.00 -0.39 -0.17 -2.35 -684 6.28 37 -2.26
Net Cash From Continuing Investing Activities		 - -0.01 - -0.00 -0.39 -0.17 -2.35 -684 6.28 37 -2.26
Purchase of Property, Plant & Equipment		 - -0.01 - -0.00 -0.39 -0.17 -0.06 -0.00 -0.00 0.00 -0.60
Divestitures		 - - - - - 0.00 - - - 8.73 -0.06
Other Investing Activities, net		 - - - - - 0.00 - -639 -14 17 -1.60
Net Cash From Financing Activities		 0.58 -0.01 5.37 -0.05 -0.08 -0.10 9.14 715 -0.31 -0.56 -9.21
Net Cash From Continuing Financing Activities		 0.58 -0.01 5.37 -0.05 -0.08 -0.10 9.14 715 -0.31 -0.56 -9.21
Repayment of Debt		 -0.03 -0.06 -0.49 -0.05 -0.06 -0.08 -0.07 -204 - 0.00 -9.40
Other Financing Activities, net		 - 0.00 - - -0.00 -0.00 9.22 203 - 0.00 0.19
Cash Interest Paid		 0.02 0.00 0.02 0.00 0.00 0.00 0.00 -0.00 - 0.00 1.45

Annual Balance Sheets for Kindly MD

This table presents Kindly MD's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2023 2024 2025
Period end date 12/31/2023 12/31/2024 12/31/2025
Total Assets		 1.10 3.68 731
Total Current Assets		 0.62 2.51 224
Cash & Equivalents		 0.53 2.27 21
Prepaid Expenses		 0.00 0.23 2.14
Other Current Assets		 - 0.00 199
Other Current Nonoperating Assets		 - - 1.55
Plant, Property, & Equipment, net		 0.24 0.00 0.00
Total Noncurrent Assets		 0.25 1.17 507
Long-Term Investments		 - 0.00 36
Goodwill		 - - 0.00
Intangible Assets		 0.00 0.00 3.01
Other Noncurrent Operating Assets		 0.25 1.17 468
Other Noncurrent Nonoperating Assets		 - - 0.54
Total Liabilities & Shareholders' Equity		 1.10 3.68 731
Total Liabilities		 1.21 1.11 216
Total Current Liabilities		 0.81 0.61 216
Short-Term Debt		 0.15 0.14 210
Accounts Payable		 0.33 0.32 5.04
Other Current Liabilities		 0.33 0.14 0.44
Other Current Nonoperating Liabilities		 - - 0.95
Total Noncurrent Liabilities		 0.39 0.50 0.37
Noncurrent Deferred & Payable Income Tax Liabilities		 - - 0.00
Other Noncurrent Operating Liabilities		 0.16 0.50 0.00
Other Noncurrent Nonoperating Liabilities		 - - 0.37
Total Equity & Noncontrolling Interests		 -0.11 2.57 514
Total Preferred & Common Equity		 -0.11 2.57 514
Preferred Stock		 0.00 0.00 0.00
Total Common Equity		 -0.11 2.57 514
Common Stock		 4.05 10 575
Retained Earnings		 -4.16 -7.78 -60
Treasury Stock		 0.00 -0.02 -0.75
Accumulated Other Comprehensive Income / (Loss)		 - - 0.00

Quarterly Balance Sheets for Kindly MD

This table presents Kindly MD's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026
Period end date 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026 6/30/2026
Total Assets		 0.80 5.46 4.32 2.56 9.89 692 621 423
Total Current Assets		 0.36 5.05 3.94 1.29 6.37 27 63 27
Cash & Equivalents		 0.29 4.74 3.64 1.14 6.02 24 35 19
Prepaid Expenses		 0.01 0.31 0.25 0.14 0.34 2.87 14 4.49
Other Current Assets		 - - - - - - 14 3.89
Other Current Nonoperating Assets		 - - - - - - - 0.00
Plant, Property, & Equipment, net		 0.22 0.21 0.18 0.11 0.08 0.00 0.00 0.00
Total Noncurrent Assets		 0.22 0.20 0.20 1.16 3.43 665 557 395
Long-Term Investments		 - - - - - 46 17 18
Goodwill		 - - - - - - 94 16
Intangible Assets		 - - - 0.56 0.62 3.01 101 97
Other Noncurrent Operating Assets		 0.22 0.20 0.20 0.60 0.56 616 0.19 264
Other Noncurrent Nonoperating Assets		 - - - - 2.25 - 346 0.00
Total Liabilities & Shareholders' Equity		 0.80 5.46 4.32 2.56 9.89 692 621 423
Total Liabilities		 1.18 1.08 0.84 1.03 0.92 215 254 186
Total Current Liabilities		 0.86 0.94 0.73 0.56 0.49 214 252 179
Short-Term Debt		 0.20 0.23 0.19 0.06 0.00 203 210 165
Accounts Payable		 0.30 0.63 0.43 0.37 0.36 5.85 13 11
Current Deferred Revenue		 - - - - - - 23 3.45
Other Current Liabilities		 0.36 0.08 0.10 0.13 0.13 5.60 5.75 0.35
Other Current Nonoperating Liabilities		 - - - - - - - 0.00
Total Noncurrent Liabilities		 0.32 0.13 0.11 0.47 0.43 0.40 1.99 6.63
Noncurrent Deferred Revenue		 - - - - - - 1.62 3.78
Noncurrent Deferred & Payable Income Tax Liabilities		 - - - - - - - 2.50
Other Noncurrent Operating Liabilities		 0.14 0.13 0.11 0.47 0.43 0.40 0.37 0.35
Other Noncurrent Nonoperating Liabilities		 - - - - - - - 0.00
Total Equity & Noncontrolling Interests		 -0.38 4.38 3.48 1.53 8.97 478 367 236
Total Preferred & Common Equity		 -0.38 4.38 3.48 1.53 8.97 478 367 236
Preferred Stock		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 -0.38 4.38 3.48 1.53 8.97 478 367 236
Common Stock		 4.06 10 10 10 20 575 666 668
Retained Earnings		 -4.44 -5.76 -6.77 -8.81 -11 -97 -299 -432
Treasury Stock		 - - - -0.03 0.00 0.00 0.00 0.00
Accumulated Other Comprehensive Income / (Loss)		 - - - - - - -0.13 -0.22

Annual Metrics And Ratios for Kindly MD

This table displays calculated financial ratios and metrics derived from Kindly MD's official financial filings.

Metric 2023 2024 2025
Period end date 12/31/2023 12/31/2024 12/31/2025
DEI Shares Outstanding		 0.00 5,977,476.00 439,850,889.00
DEI Adjusted Shares Outstanding		 0.00 5,977,476.00 439,850,889.00
DEI Earnings Per Adjusted Shares Outstanding		 0.00 -0.61 -0.12
Growth Metrics		 - - -
Revenue Growth		 0.00% -27.83% -33.04%
EBITDA Growth		 0.00% -93.60% -956.88%
EBIT Growth		 0.00% -103.98% -855.82%
NOPAT Growth		 0.00% -106.56% -5,790.43%
Net Income Growth		 0.00% -123.66% -1,343.73%
EPS Growth		 0.00% -86.11% 61.19%
Operating Cash Flow Growth		 0.00% -583.86% -664.88%
Free Cash Flow Firm Growth		 0.00% 0.00% -26,376.71%
Invested Capital Growth		 0.00% 269.17% 153,262.15%
Revenue Q/Q Growth		 0.00% -5.41% -8.03%
EBITDA Q/Q Growth		 0.00% -38.40% 63.56%
EBIT Q/Q Growth		 0.00% -28.35% 59.95%
NOPAT Q/Q Growth		 0.00% -27.43% -1,226.52%
Net Income Q/Q Growth		 0.00% -23.01% 42.28%
EPS Q/Q Growth		 0.00% -17.54% 76.79%
Operating Cash Flow Q/Q Growth		 0.00% -29.10% -39.57%
Free Cash Flow Firm Q/Q Growth		 0.00% 0.00% -29.36%
Invested Capital Q/Q Growth		 0.00% 1,046.96% 9.03%
Profitability Metrics		 - - -
Gross Margin		 100.00% 100.00% 100.00%
EBITDA Margin		 -35.51% -95.24% -1,503.20%
Operating Margin		 -42.99% -123.05% -10,824.01%
EBIT Margin		 -41.44% -117.11% -1,671.63%
Profit (Net Income) Margin		 -42.92% -133.01% -2,867.65%
Tax Burden Percent		 100.00% 100.00% 100.00%
Interest Burden Percent		 103.58% 113.57% 171.55%
Effective Tax Rate		 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)		 0.00% -2,640.61% -41.44%
ROIC Less NNEP Spread (ROIC-NNEP)		 0.00% -2,528.90% 73.57%
Return on Net Nonoperating Assets (RNNOA)		 0.00% 2,346.48% 21.23%
Return on Equity (ROE)		 1,491.96% -294.13% -20.21%
Cash Return on Invested Capital (CROIC)		 0.00% -698.96% -241.18%
Operating Return on Assets (OROA)		 -142.07% -133.35% -8.29%
Return on Assets (ROA)		 -147.15% -151.45% -14.23%
Return on Common Equity (ROCE)		 1,491.96% -294.13% -20.21%
Return on Equity Simple (ROE_SIMPLE)		 1,491.96% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)		 -1.13 -2.34 -138
NOPAT Margin		 -30.09% -86.14% -7,576.80%
Net Nonoperating Expense Percent (NNEP)		 -326.31% -111.71% -115.01%
Return On Investment Capital (ROIC_SIMPLE)		 -421.66% -86.53% -19.07%
Cost of Revenue to Revenue		 0.00% 0.00% 0.00%
SG&A Expenses to Revenue		 35.98% 70.12% 645.82%
R&D to Revenue		 0.07% 0.00% 0.00%
Operating Expenses to Revenue		 142.99% 223.05% 10,924.01%
Earnings before Interest and Taxes (EBIT)		 -1.56 -3.19 -30
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -1.34 -2.59 -27
Valuation Ratios		 - - -
Price to Book Value (P/BV)		 0.00 2.89 0.30
Price to Tangible Book Value (P/TBV)		 0.00 2.89 0.30
Price to Revenue (P/Rev)		 1.86 2.73 84.79
Price to Earnings (P/E)		 0.00 0.00 0.00
Dividend Yield		 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 0.00 12.16 0.46
Enterprise Value to Revenue (EV/Rev)		 1.82 1.94 167.85
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00
Leverage & Solvency		 - - -
Debt to Equity		 -3.48 0.05 0.41
Long-Term Debt to Equity		 -2.11 0.00 0.00
Financial Leverage		 1.37 -0.93 0.29
Leverage Ratio		 -10.14 1.94 1.42
Compound Leverage Factor		 -10.50 2.21 2.44
Debt to Total Capital		 140.31% 5.14% 28.95%
Short-Term Debt to Total Capital		 55.22% 5.14% 28.95%
Long-Term Debt to Total Capital		 85.09% 0.00% 0.00%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00%
Common Equity to Total Capital		 -40.31% 94.86% 71.05%
Debt to EBITDA		 -0.28 -0.05 -7.65
Net Debt to EBITDA		 0.11 0.82 -5.53
Long-Term Debt to EBITDA		 -0.17 0.00 0.00
Debt to NOPAT		 -0.33 -0.06 -1.52
Net Debt to NOPAT		 0.13 0.91 -1.10
Long-Term Debt to NOPAT		 -0.20 0.00 0.00
Altman Z-Score		 -3.29 -0.45 0.19
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00%
Liquidity Ratios		 - - -
Current Ratio		 0.76 4.13 1.04
Quick Ratio		 0.68 3.75 0.10
Cash Flow Metrics		 - - -
Free Cash Flow to Firm (FCFF)		 0.00 -3.03 -803
Operating Cash Flow to CapEx		 -3,117.12% -765.35% -10,031.23%
Free Cash Flow to Firm to Interest Expense		 0.00 -7.02 -36.87
Operating Cash Flow to Interest Expense		 -8.05 -7.11 -1.08
Operating Cash Flow Less CapEx to Interest Expense		 -8.31 -8.04 -1.09
Efficiency Ratios		 - - -
Asset Turnover		 3.43 1.14 0.01
Accounts Receivable Turnover		 134.59 0.00 0.00
Inventory Turnover		 0.00 0.00 0.00
Fixed Asset Turnover		 16.02 0.00 0.00
Accounts Payable Turnover		 0.00 0.00 0.00
Days Sales Outstanding (DSO)		 2.71 0.00 0.00
Days Inventory Outstanding (DIO)		 0.00 0.00 0.00
Days Payable Outstanding (DPO)		 0.00 0.00 0.00
Cash Conversion Cycle (CCC)		 2.71 0.00 0.00
Capital & Investment Metrics		 - - -
Invested Capital		 -0.26 0.43 666
Invested Capital Turnover		 -14.69 30.66 0.01
Increase / (Decrease) in Invested Capital		 0.00 0.69 665
Enterprise Value (EV)		 6.85 5.28 306
Market Capitalization		 7.00 7.41 154
Book Value per Share		 ($0.02) $0.43 $1.17
Tangible Book Value per Share		 ($0.02) $0.43 $1.16
Total Capital		 0.27 2.71 724
Total Debt		 0.38 0.14 210
Total Long-Term Debt		 0.23 0.00 0.00
Net Debt		 -0.15 -2.13 151
Capital Expenditures (CapEx)		 0.01 0.40 0.23
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 -0.57 -0.23 195
Debt-free Net Working Capital (DFNWC)		 -0.05 2.04 217
Net Working Capital (NWC)		 -0.20 1.90 7.83
Net Nonoperating Expense (NNE)		 0.48 1.27 -86
Net Nonoperating Obligations (NNO)		 -0.15 -2.13 151
Total Depreciation and Amortization (D&A)		 0.22 0.59 3.07
Debt-free, Cash-free Net Working Capital to Revenue		 -15.24% -8.63% 10,695.95%
Debt-free Net Working Capital to Revenue		 -1.30% 74.96% 11,935.88%
Net Working Capital to Revenue		 -5.24% 69.84% 430.02%
Earnings Adjustments		 - - -
Adjusted Basic Earnings per Share		 $0.00 ($0.67) ($0.26)
Adjusted Weighted Average Basic Shares Outstanding		 0.00 5.39M 200.20M
Adjusted Diluted Earnings per Share		 $0.00 ($0.67) ($0.26)
Adjusted Weighted Average Diluted Shares Outstanding		 0.00 5.39M 200.20M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 0.00 6.03M 690.02M
Normalized Net Operating Profit after Tax (NOPAT)		 -1.13 -2.34 -138
Normalized NOPAT Margin		 -30.09% -86.14% -7,576.80%
Pre Tax Income Margin		 -42.92% -133.01% -2,867.65%
Debt Service Ratios		 - - -
EBIT to Interest Expense		 -27.96 -7.37 -1.40
NOPAT to Interest Expense		 -20.31 -5.42 -6.34
EBIT Less CapEx to Interest Expense		 -28.22 -8.30 -1.41
NOPAT Less CapEx to Interest Expense		 -20.57 -6.35 -6.35
Payout Ratios		 - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00%
Augmented Payout Ratio		 0.00% -0.61% -0.61%

Quarterly Metrics And Ratios for Kindly MD

This table displays calculated financial ratios and metrics derived from Kindly MD's official financial filings.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
DEI Shares Outstanding		 0.00 0.00 5,939,516.00 5,947,169.00 5,977,476.00 6,029,648.00 6,022,148.00 7,606,339.00 439,850,889.00 690,018,254.00 696,085,586.00
DEI Adjusted Shares Outstanding		 0.00 0.00 5,939,516.00 5,947,169.00 5,977,476.00 6,029,648.00 6,022,148.00 7,606,339.00 439,850,889.00 690,018,254.00 17,402,140.00
DEI Earnings Per Adjusted Shares Outstanding		 0.00 0.00 -0.22 -0.17 -0.17 -0.17 -0.40 -11.31 0.08 -0.35 -7.64
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 0.00% -28.55% -34.76% -25.47% -20.48% -30.04% -36.07% -40.08% -26.32% 361.72% 0.00%
EBITDA Growth		 0.00% -3.49% -12.87% -95.08% -362.57% -694.86% -292.32% -7,399.52% 5,207.89% -22,921.79% -812,083.33%
EBIT Growth		 0.00% -24.37% -63.60% -99.86% -242.76% -358.49% -150.45% -7,026.15% 4,587.26% -22,628.29% 0.00%
NOPAT Growth		 0.00% -15.56% -72.49% -105.20% -238.48% -339.43% -130.57% -891.17% -25,506.24% -12,008.45% 0.00%
Net Income Growth		 0.00% -56.00% -121.27% -96.87% -208.23% -267.66% -82.91% -8,383.56% 3,820.21% -22,903.47% -5,409.40%
EPS Growth		 0.00% -50.00% -100.00% -54.55% -125.00% -183.33% -34.62% -147.06% 477.78% -123.53% 53.17%
Operating Cash Flow Growth		 0.00% -227.73% -106.65% -3,160.44% -332.01% -305.27% -109.21% -1,159.60% -739.41% -2,591.91% -70.23%
Free Cash Flow Firm Growth		 0.00% 0.00% 0.00% 0.00% 0.00% -1,229.92% -319.84% -79,837.50% -60,227.34% -17,894.97% -56,777.33%
Invested Capital Growth		 0.00% 0.00% 0.00% 0.00% 269.17% 253.59% 627.21% 1,613,278.46% 153,262.15% 39,116.07% 52,583.15%
Revenue Q/Q Growth		 -12.63% 9.16% -22.92% 1.38% -6.79% -3.96% -29.52% -4.97% 14.61% 501.90% 1,239.40%
EBITDA Q/Q Growth		 59.10% 35.65% -370.51% -57.54% 3.02% -10.57% -148.21% -2,911.50% 166.05% -598.36% 37.37%
EBIT Q/Q Growth		 42.33% 22.34% -327.53% -4.38% 1.10% -3.88% -133.61% -2,870.03% 162.28% -626.18% 36.64%
NOPAT Q/Q Growth		 40.94% 21.51% -337.40% -1.22% 2.59% -1.89% -129.57% -335.11% -2,416.53% 51.82% -18.16%
Net Income Q/Q Growth		 36.93% 13.11% -367.42% 23.15% 1.25% -3.64% -132.54% -3,464.35% 143.31% -740.86% 44.30%
EPS Q/Q Growth		 27.27% 25.00% -333.33% 34.62% -5.88% 5.56% -105.88% -20.00% 261.90% -155.88% -1,650.00%
Operating Cash Flow Q/Q Growth		 -710.93% -2.28% -328.01% -14.43% 13.76% 4.05% -120.93% -588.97% 42.53% -207.70% 86.03%
Free Cash Flow Firm Q/Q Growth		 0.00% 0.00% -553.12% -29.91% -82.00% -5.47% -68.38% -24,635.32% -37.35% 68.54% -75.41%
Invested Capital Q/Q Growth		 0.00% -15.88% 55.85% 128.83% 1,046.96% 5.20% 51.55% 88,127.21% 9.03% -73.10% 103.59%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
EBITDA Margin		 -26.10% -15.39% -93.92% -145.96% -151.86% -174.83% -576.42% -18,267.49% 10,528.00% -8,716.99% -407.57%
Operating Margin		 -39.78% -28.60% -162.30% -162.04% -169.34% -179.66% -585.39% -2,680.39% -41,198.16% -4,711.35% -415.62%
EBIT Margin		 -38.16% -27.15% -150.58% -155.05% -164.50% -177.93% -589.95% -18,438.86% 10,019.11% -8,758.63% -414.30%
Profit (Net Income) Margin		 -42.78% -34.06% -206.50% -156.54% -165.85% -178.97% -590.85% -22,162.24% 8,374.17% -8,916.21% -370.79%
Tax Burden Percent		 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 87.14%
Interest Burden Percent		 112.11% 125.43% 137.13% 100.96% 100.82% 100.58% 100.15% 120.19% 83.58% 101.80% 102.70%
Effective Tax Rate		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)		 0.00% 0.00% 0.00% -17,240.48% -3,634.01% -3,901.38% -3,274.28% -12.17% -225.34% -144.02% -63.39%
ROIC Less NNEP Spread (ROIC-NNEP)		 0.00% 0.00% 0.00% -17,224.27% -3,608.98% -3,838.83% -3,262.70% -133.86% 70.43% 15.10% -111.20%
Return on Net Nonoperating Assets (RNNOA)		 0.00% 0.00% 0.00% 17,037.22% 3,348.65% 3,305.21% 3,125.66% -36.02% 20.32% -7.75% -54.30%
Return on Equity (ROE)		 1,491.96% 448.63% -55.75% -203.26% -285.36% -596.17% -148.62% -48.19% -205.02% -151.77% -117.70%
Cash Return on Invested Capital (CROIC)		 0.00% 0.00% 0.00% 0.00% -698.96% -801.66% -675.99% -203.38% -241.18% -450.34% -379.93%
Operating Return on Assets (OROA)		 -130.84% -116.76% -85.46% -103.10% -187.32% -261.46% -172.21% -104.81% 49.70% -110.14% -76.25%
Return on Assets (ROA)		 -146.69% -146.45% -117.19% -104.09% -188.84% -262.98% -172.47% -125.98% 41.54% -112.13% -68.24%
Return on Common Equity (ROCE)		 1,491.96% 448.63% -55.75% -203.26% -285.36% -596.17% -148.62% -48.19% -205.02% -151.77% -117.70%
Return on Equity Simple (ROE_SIMPLE)		 0.00% 448.63% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)		 -0.21 -0.17 -0.73 -0.73 -0.72 -0.73 -1.67 -7.28 -183 -88 -104
NOPAT Margin		 -27.85% -20.02% -113.61% -113.43% -118.54% -125.76% -409.78% -1,876.27% -41,198.16% -3,297.95% -290.93%
Net Nonoperating Expense Percent (NNEP)		 -76.59% 270.97% -26.31% -16.21% -25.03% -62.56% -11.57% 121.69% -295.77% -159.12% 47.81%
Return On Investment Capital (ROIC_SIMPLE)		 -78.63% 1,681.41% -15.75% -19.97% -26.44% -45.67% -18.67% -1.07% -25.32% -15.31% -26.02%
Cost of Revenue to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
SG&A Expenses to Revenue		 35.92% 35.00% 69.47% 81.15% 107.17% 102.24% 274.52% 1,283.52% 1,138.55% 365.35% 13.09%
R&D to Revenue		 0.00% 4.27% 53.57% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue		 139.78% 128.60% 262.30% 262.04% 269.34% 279.66% 685.39% 2,780.39% 41,298.16% 4,811.35% 515.62%
Earnings before Interest and Taxes (EBIT)		 -0.29 -0.23 -0.96 -1.00 -0.99 -1.03 -2.41 -72 45 -235 -149
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -0.20 -0.13 -0.60 -0.95 -0.92 -1.01 -2.35 -71 47 -233 -146
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 0.00 0.00 3.73 1.79 2.89 6.35 9.30 0.02 0.30 0.42 0.29
Price to Tangible Book Value (P/TBV)		 0.00 0.00 3.73 1.79 2.89 10.04 9.99 0.02 0.30 0.88 0.56
Price to Revenue (P/Rev)		 1.86 2.04 5.27 2.17 2.73 3.93 37.22 4.11 84.79 38.89 1.73
Price to Earnings (P/E)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 0.00 0.00 0.00 73.96 12.16 18.91 111.80 0.23 0.46 1.73 0.54
Enterprise Value to Revenue (EV/Rev)		 1.82 2.06 3.82 0.97 1.94 3.49 34.53 71.21 167.85 79.09 4.95
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 -3.48 -0.97 0.05 0.06 0.05 0.04 0.00 0.43 0.41 0.57 0.70
Long-Term Debt to Equity		 -2.11 -0.46 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Financial Leverage		 1.37 -0.22 -1.03 -0.99 -0.93 -0.86 -0.96 0.27 0.29 -0.51 0.49
Leverage Ratio		 -10.14 -2.09 1.25 1.24 1.94 2.93 1.15 1.45 1.42 1.69 1.76
Compound Leverage Factor		 -11.37 -2.62 1.71 1.25 1.96 2.95 1.15 1.74 1.19 1.72 1.81
Debt to Total Capital		 140.31% -3,780.90% 4.95% 5.34% 5.14% 4.26% 0.00% 29.83% 28.95% 36.36% 41.06%
Short-Term Debt to Total Capital		 55.22% -1,985.05% 4.95% 5.12% 5.14% 3.82% 0.00% 29.83% 28.95% 36.36% 41.06%
Long-Term Debt to Total Capital		 85.09% -1,795.85% 0.00% 0.22% 0.00% 0.44% 0.00% 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 -40.31% 3,880.90% 95.05% 94.66% 94.86% 95.74% 100.00% 70.17% 71.05% 63.64% 58.94%
Debt to EBITDA		 -0.28 -0.28 -0.16 -0.11 -0.05 -0.02 0.00 -2.70 -7.65 -0.80 -0.40
Net Debt to EBITDA		 0.11 -0.06 3.20 1.84 0.82 0.28 0.00 -1.77 -5.53 -0.60 -0.31
Long-Term Debt to EBITDA		 -0.17 -0.13 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt to NOPAT		 -0.33 -0.32 -0.16 -0.11 -0.06 -0.02 0.00 -19.52 -1.52 -0.93 -0.50
Net Debt to NOPAT		 0.13 -0.07 3.09 1.87 0.91 0.37 0.00 -12.77 -1.10 -0.70 -0.39
Long-Term Debt to NOPAT		 -0.20 -0.15 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Altman Z-Score		 0.52 -1.61 8.52 3.06 1.52 0.80 52.72 -0.84 0.53 -1.92 -2.71
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 0.76 0.41 5.36 5.43 4.13 2.30 12.99 0.13 1.04 0.25 0.15
Quick Ratio		 0.68 0.34 5.03 5.08 3.75 2.05 12.30 0.11 0.10 0.14 0.11
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 0.00 0.13 -0.59 -0.77 -1.41 -1.48 -2.50 -618 -848 -267 -468
Operating Cash Flow to CapEx		 0.00% -1,908.77% 0.00% -49,567.80% -232.15% -500.00% -3,290.95% -460,568.94% -756,753,100.00% 0.00% -542.17%
Free Cash Flow to Firm to Interest Expense		 0.00 2.29 -1.66 -80.00 -173.62 -247.20 -680.80 -42.73 -115.92 -63.25 -116.58
Operating Cash Flow to Interest Expense		 -5.95 -3.73 -2.56 -108.23 -111.30 -144.17 -521.05 -0.91 -1.03 -5.52 -0.81
Operating Cash Flow Less CapEx to Interest Expense		 -5.95 -3.92 -2.56 -108.45 -159.24 -173.00 -536.89 -0.91 -1.03 -5.52 -0.96
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 3.43 4.30 0.57 0.67 1.14 1.47 0.29 0.01 0.01 0.01 0.18
Accounts Receivable Turnover		 134.59 455.03 597.61 63.44 0.00 233.45 354.03 0.00 0.00 0.00 0.00
Inventory Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover		 16.02 15.51 14.97 15.68 0.00 15.12 15.40 0.00 0.00 0.00 0.00
Accounts Payable Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Sales Outstanding (DSO)		 2.71 0.80 0.61 5.75 0.00 1.56 1.03 0.00 0.00 0.00 0.00
Days Inventory Outstanding (DIO)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Cash Conversion Cycle (CCC)		 2.71 0.80 0.61 5.75 0.00 1.56 1.03 0.00 0.00 0.00 0.00
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 -0.26 -0.30 -0.13 0.04 0.43 0.46 0.69 610 666 179 365
Invested Capital Turnover		 -14.69 -23.13 -47.19 151.99 30.66 31.02 7.99 0.01 0.01 0.04 0.22
Increase / (Decrease) in Invested Capital		 0.00 -0.30 -0.13 0.04 0.69 0.75 0.82 610 665 179 364
Enterprise Value (EV)		 6.85 7.09 12 2.80 5.28 8.64 77 141 306 310 197
Market Capitalization		 7.00 7.00 16 6.24 7.41 9.71 83 8.14 154 152 69
Book Value per Share		 ($0.02) ($0.08) $0.74 $0.59 $0.43 $0.25 $1.49 $62.78 $1.17 $0.53 $0.34
Tangible Book Value per Share		 ($0.02) ($0.08) $0.74 $0.59 $0.43 $0.16 $1.39 $62.39 $1.16 $0.25 $0.18
Total Capital		 0.27 -0.01 4.61 3.68 2.71 1.60 8.97 681 724 577 401
Total Debt		 0.38 0.37 0.23 0.20 0.14 0.07 0.00 203 210 210 165
Total Long-Term Debt		 0.23 0.18 0.00 0.01 0.00 0.01 0.00 0.00 0.00 0.00 0.00
Net Debt		 -0.15 0.09 -4.51 -3.45 -2.13 -1.07 -6.02 133 151 158 128
Capital Expenditures (CapEx)		 0.00 0.01 0.00 0.00 0.39 0.17 0.06 0.00 0.00 0.00 0.60
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 -0.57 -0.60 -0.40 -0.24 -0.23 -0.35 -0.14 -8.58 195 -14 -6.39
Debt-free Net Working Capital (DFNWC)		 -0.05 -0.31 4.34 3.40 2.04 0.79 5.88 16 217 21 13
Net Working Capital (NWC)		 -0.20 -0.51 4.11 3.22 1.90 0.73 5.88 -187 7.83 -188 -152
Net Nonoperating Expense (NNE)		 0.11 0.12 0.59 0.28 0.29 0.31 0.74 79 -221 150 29
Net Nonoperating Obligations (NNO)		 -0.15 0.09 -4.51 -3.45 -2.13 -1.07 -8.27 133 151 -188 128
Total Depreciation and Amortization (D&A)		 0.09 0.10 0.36 0.06 0.08 0.02 0.06 0.67 2.26 1.12 2.41
Debt-free, Cash-free Net Working Capital to Revenue		 -15.24% -17.36% -12.92% -8.31% -8.63% -14.06% -6.37% -433.04% 10,695.95% -353.12% -16.06%
Debt-free Net Working Capital to Revenue		 -1.30% -9.00% 140.14% 118.39% 74.96% 32.10% 262.59% 788.26% 11,935.88% 547.54% 31.87%
Net Working Capital to Revenue		 -5.24% -14.70% 132.77% 111.83% 69.84% 29.63% 262.59% -9,463.71% 430.02% -4,803.90% -382.08%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 ($0.08) ($0.06) ($0.26) ($0.17) ($0.18) ($0.17) ($0.35) ($0.42) $0.68 ($0.38) ($6.65)
Adjusted Weighted Average Basic Shares Outstanding		 4.50M 4.62M 5.01M 5.94M 5.39M 6.02M 6.82M 203.09M 200.20M 636.47M 20M
Adjusted Diluted Earnings per Share		 ($0.08) ($0.06) ($0.26) ($0.17) ($0.18) ($0.17) ($0.35) ($0.42) $0.68 ($0.38) ($6.65)
Adjusted Weighted Average Diluted Shares Outstanding		 4.50M 4.62M 5.01M 5.94M 5.39M 6.02M 6.82M 203.09M 200.20M 636.47M 20M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 0.00 5.94M 5.95M 5.98M 6.03M 6.02M 7.61M 439.85M 690.02M 696.09M 17.89M
Normalized Net Operating Profit after Tax (NOPAT)		 -0.21 -0.17 -0.73 -0.73 -0.72 -0.73 -1.67 -7.28 -128 -88 -31
Normalized NOPAT Margin		 -27.85% -20.02% -113.61% -113.43% -118.54% -125.76% -409.78% -1,876.27% -28,838.71% -3,297.95% -85.68%
Pre Tax Income Margin		 -42.78% -34.06% -206.50% -156.54% -165.85% -178.97% -590.85% -22,162.24% 8,374.17% -8,916.21% -425.50%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 -8.26 -3.93 -2.69 -104.00 -122.64 -172.00 -657.07 -4.95 6.09 -55.58 -37.00
NOPAT to Interest Expense		 -6.03 -2.90 -2.03 -76.08 -88.38 -121.57 -456.39 -0.50 -25.05 -20.93 -25.98
EBIT Less CapEx to Interest Expense		 -8.26 -4.13 -2.69 -104.21 -170.59 -200.83 -672.90 -4.95 6.09 -55.58 -37.15
NOPAT Less CapEx to Interest Expense		 -6.03 -3.10 -2.03 -76.30 -136.32 -150.40 -472.22 -0.50 -25.05 -20.93 -26.13
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 0.00% 0.00% 0.00% 0.00% -0.61% -0.74% -0.58% 0.00% -0.61% -0.30% -0.21%

Financials Breakdown Chart

Key Financial Trends

KindlyMD’s Q2 2026 results show a sharp increase in reported revenue, but the company remains deeply unprofitable and cash flow is still negative. Revenue rose to $35.9 million from $2.7 million in Q1 2026 and less than $1 million in each reported quarter of 2024 and 2025. However, the income statement reports no cost of revenue, so the implied 100% gross margin should not be treated as economically meaningful without additional disclosure.

The improvement in operating cash flow was more limited than the revenue growth suggests. Net cash used in operating activities improved to $3.3 million in Q2 from $23.3 million in Q1, while continuing operating cash flow was negative $1.1 million. This result depended heavily on $140.6 million of noncash adjustments, including the impact of large accounting charges. Cash declined by $14.7 million during the quarter to $19.1 million, despite the company reporting $236.4 million of shareholders’ equity.

  • Revenue accelerated materially: Q2 2026 revenue of $35.9 million was more than 13 times Q1 revenue and substantially above the sub-$1 million quarterly revenue reported through 2025.
  • Operating cash burn improved sequentially: Net cash used in operating activities fell from $23.3 million in Q1 2026 to $3.3 million in Q2.
  • Short-term debt declined: Short-term debt fell from $209.7 million at March 31, 2026, to $164.7 million at June 30, 2026, following $9.4 million of debt repayment during Q2.
  • Shareholders’ equity remains positive: Total equity was $236.4 million at the end of Q2, providing some balance-sheet cushion despite substantial accumulated losses.
  • Reported assets changed significantly: Total assets declined from $620.8 million in Q1 to $422.5 million in Q2, while goodwill, intangible assets and other noncurrent assets shifted considerably. Investors should review acquisition accounting and valuation assumptions before relying on book value.
  • Cash flow benefited from noncash accounting adjustments: Q2 included $140.6 million of noncash adjustments, offsetting most of the reported $133.0 million net loss. This makes net income a poor proxy for near-term cash generation.
  • Financial statement comparability is limited: Several earlier 2024 and 2025 income statement periods were marked as restated or calculated, and the supplied data identifies the company as KDLY rather than the NAKA ticker cited in the request.
  • Q2 produced a substantial net loss: Consolidated net loss was $133.0 million, including a $105.2 million impairment charge and $72.6 million of other operating expenses.
  • Liquidity is weak relative to current obligations: Cash of $19.1 million and total current assets of $27.5 million compared with $179.5 million of current liabilities, including $164.7 million of short-term debt.
  • Cash reserves are shrinking: Cash fell from $35.3 million at the end of Q1 to $19.1 million at the end of Q2, while total Q2 cash outflows included $2.3 million for investing and $9.2 million for financing activities.

Overall, the revenue increase is a potentially important positive development, but it has not yet translated into sustainable profitability or positive free cash flow. The combination of large impairment charges, deeply negative retained earnings of $431.8 million, significant short-term debt and declining cash leaves the company dependent on a successful operating turnaround, asset monetization or additional financing.

08/22/26 12:06 PM ETAI Generated. May Contain Errors.

Kindly MD Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Kindly MD's fiscal year ends in December. Their fiscal year 2025 ended on December 31, 2025.

Kindly MD's net income appears to be on an upward trend, with a most recent value of -$52.23 million in 2025, rising from -$1.62 million in 2023. The previous period was -$3.62 million in 2024.

Kindly MD's total operating income in 2025 was -$197.14 million, based on the following breakdown:
  • Total Gross Profit: $1.82 million
  • Total Operating Expenses: $198.96 million

Over the last 2 years, Kindly MD's total revenue changed from $3.77 million in 2023 to $1.82 million in 2025, a change of -51.7%.

Kindly MD's total liabilities were at $216.35 million at the end of 2025, a 19,396.7% increase from 2024, and a 17,815.6% increase since 2023.

In the past 2 years, Kindly MD's cash and equivalents has ranged from $525.50 thousand in 2023 to $21.07 million in 2025, and is currently $21.07 million as of their latest financial filing in 2025.

Over the last 2 years, Kindly MD's book value per share changed from -0.02 in 2023 to 1.17 in 2025, a change of -4,951.5%.


Related Companies

Financial statements for NASDAQ:NAKAW last updated on 8/13/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners
The retirement stock I'd buy before Nvidia today
In 2014, Marc Chaikin pointed readers toward Nvidia. Now the 60-year Wall Street veteran and creator of the Ch...
Chaikin Analytics | Sponsoredtc pixel
They didn't warn anyone in 1971. This time someone is warning you.
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Someone just dumped the biggest gold fund.
Investors pulled 2.9 billion dollars from the world's largest gold fund in a single day this March, pushing to...
Behind the Markets | Sponsoredtc pixel
These gold assets are priced for $1,800 gold [it's over $4,000]
Gold's major miners are generating record free cash flow, with margins as high as 75 percent even after gold's...
Golden Portfolio | Sponsoredtc pixel
A $382 trillion migration and the position no one is talking about
Trump just signed a law requiring America's entire $382 trillion financial system to migrate to a new money ne...
Awesomely | Sponsoredtc pixel
Man who Predicted Trump 2016 Win: “Prepare for Mid-Term Meltdown”
In 2016, major election models gave Hillary Clinton a 99% chance of winning - but former CIA and Pentagon advi...
Paradigm Press | Sponsoredtc pixel
Your withdrawal order could cost you in taxes
If you have $2M or more saved, the 4% rule points to roughly $92,000 a year - but it's a single-variable answe...
SmartAsset | Sponsoredtc pixel
Trump’s New Currency Reset
Trump is launching a new $250 bill - but that may be a distraction. Behind the scenes, Executive Order 14241 i...
Porter & Company | Sponsoredtc pixel